Pharmaceutical News

RSS

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

Maxygen receives approval for trial of factor VIIa in UK

Maxygen, Inc. today announced that it has filed a Clinical Trial Authorization (CTA) and received the necessary approvals in the United Kingdom to initiate a first-in-human Phase I trial of MAXY-VII in hemophilia patients.

11 Jun 2008

Hope on the horizon for migraine sufferers

A generation of anti-migraine drugs with fewer side effects than existing treatments could be available to sufferers within three years.

11 Jun 2008

Sen. Grassley issues report on conflict-of-interest probe into improper payment disclosures by three Harvard psychiatrists

Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).

10 Jun 2008

Calls for tougher rules on complementary medicines in Australia

Pressure from a consumer group has prompted the Australian Federal Government to consider the introduction of far more stringent disclosure rules regarding complementary medicines.

10 Jun 2008

Administration proposes additional funding for FDA for fiscal year (FY) 2009

HHS Secretary Leavitt today announced that the Administration is amending its budget request for fiscal year (FY) 2009 to include an additional $275 million for the U.S. Food and Drug Administration (FDA). He called on Congress to act quickly on this budget amendment and pending Administration legislative proposals to strengthen FDA.

9 Jun 2008

Mylan announces final FDA approval for Zaleplon capsules, generic version of Sonata

Mylan Inc. has announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.

9 Jun 2008

Cancer warning on diabetic ulcer gel

The U.S. watchdog the Food and Drug Administration (FDA) says a warning will be added to the label of a topical gel used to treat leg and foot ulcers which refuse to heal in diabetic patients.

9 Jun 2008

Nearly 75% of Medicare drug plan beneficiaries will pay 16% more for coverage this year

Monthly premiums for Medicare beneficiaries enrolled in the 10 largest prescription drug plans this year increased by an average of 16% to $26.39, according to an analysis released on Wednesday by Avalere Health, the Los Angeles Times reports.

8 Jun 2008

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S., the AIDS Healthcare Foundation announced on Tuesday, Bloomberg reports.

8 Jun 2008

GlaxoSmithKline Acquires Sirtris Pharmaceuticals

GlaxoSmithKline has announced that it has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately USD720 million (or approx. GBP362 million) through a cash tender offer and merger of USD22.50 (or approx. GBP11.33) per share.

8 Jun 2008

FDA announces label changes for Regranex - boxed warning

The U.S. Food and Drug Administration has announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product. Regranex is a topical cream indicated for the treatment of leg and foot ulcers that are not healing in diabetic patients.

8 Jun 2008

New invaluable tool in drug manufacture

Drug companies could save millions thanks to a new technology to monitor crystals as they form.

8 Jun 2008

Arthritis drugs used in children to be investigated because of cancer link

Authorities in the United States are investigating certain types of drugs used to treat arthritis and other conditions.

5 Jun 2008

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

In a national survey released today by the Alliance of Minority Medical Associations (AMMA), Americans noted that their highest health care priority is reducing the cost of prescription drugs. Furthermore, survey respondents shared overwhelming support for creating an approval pathway for generic, or follow-on biotechnology therapies, with 86% of likely voters stating their desire for such a system.

4 Jun 2008

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.

4 Jun 2008

BN ImmunoTherapeutics starts clinical trials with prostate cancer vaccine

BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.

4 Jun 2008

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

A $9.5 million settlement with 28 states announced last week by Express Scripts to resolve allegations that the company had "been pocketing money from pharmaceutical companies to steer patients into name-brand drugs" indicates the need for "some stronger medicine" to address problems in the industry, Los Angeles Times columnist David Lazarus writes.

3 Jun 2008

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Most U.S. medical schools do not adequately limit gifts and payments from pharmaceutical companies to physicians and students, according to a report released on Tuesday by the American Medical Student Association, the New York Times reports.

3 Jun 2008

Boehringer Ingelheim, Gilead to freeze AIDS drug price

AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.

3 Jun 2008

Pharmaceutical News

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Maxygen receives approval for trial of factor VIIa in UK

Hope on the horizon for migraine sufferers

Sen. Grassley issues report on conflict-of-interest probe into improper payment disclosures by three Harvard psychiatrists

Calls for tougher rules on complementary medicines in Australia

Administration proposes additional funding for FDA for fiscal year (FY) 2009

Mylan announces final FDA approval for Zaleplon capsules, generic version of Sonata

Cancer warning on diabetic ulcer gel

Nearly 75% of Medicare drug plan beneficiaries will pay 16% more for coverage this year

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

GlaxoSmithKline Acquires Sirtris Pharmaceuticals

FDA announces label changes for Regranex - boxed warning

New invaluable tool in drug manufacture

Arthritis drugs used in children to be investigated because of cancer link

Survey shows Americans regard reducing the cost of prescription drugs as highest health care priority

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

BN ImmunoTherapeutics starts clinical trials with prostate cancer vaccine

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Boehringer Ingelheim, Gilead to freeze AIDS drug price

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Latest News